Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
0.00%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
42.90%
median of 561 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Elicio Therapeutics, Inc.
Market Cap
$36.32M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$35.58M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$37.14M
Gross Margin
27.73%
TTM Avg
29.89%
3Y Avg
31.55%
5Y Avg
33.94%
Market Cap
$34.01M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
10.20%
Market Cap
$38.90M
Gross Margin
58.16%
TTM Avg
55.59%
3Y Avg
55.93%
5Y Avg
56.24%
Market Cap
$38.31M
Gross Margin
0.00%
TTM Avg
-93.03%
3Y Avg
-21.51%
5Y Avg
10.85%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Elicio Therapeutics, Inc. (ELTX) | $36.32M | 0.00% | 0.00% | 0.00% | 0.00% |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.58M | 0.00% | 0.00% | 0.00% | 0.00% |
| Accuray Incorporated (ARAY)vs › | $37.14M | 27.73% | 29.89% | 31.55% | 33.94% |
| DocGo Inc. (DCGO)vs › | $36.38M | 30.12% | 32.64% | 32.93% | 33.24% |
| Elutia Inc (ELUT)vs › | $35.82M | 57.82% | 48.80% | 47.77% | 46.56% |
| Edesa Biotech, Inc. (EDSA)vs › | $37.81M | 0.00% | 0.00% | 0.00% | 15.78% |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.01M | 0.00% | 0.00% | 0.00% | 10.20% |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.90M | 58.16% | 55.59% | 55.93% | 56.24% |
| Incannex Healthcare Limited (IXHL)vs › | $38.31M | 0.00% | -93.03% | -21.51% | 10.85% |
| HeartBeam, Inc. (BEAT)vs › | $33.31M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 86.17% |
| 2021-12-31 | 97.47% |
| 2021-09-30 | 85.14% |
| 2021-06-30 | 61.85% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 40.74% |
| 2020-09-30 | 40.87% |
| 2020-06-30 | 31.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 37.64% |
